Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

On its clinic website, the supermarket chain said the self-injectable pens can be used once a week to increase a user’s chance of sustained weight loss, amounted to around 20% of their bodyweight in a ...

A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

SAN FRANCISCO — Data from a limited number of trials hint that GLP-1 use might improve erectile dysfunction and testosterone levels for men, but more research is needed to provide a clearer ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...

This study could significantly impact Eli Lilly’s market position by potentially enhancing their portfolio with a new obesity treatment, influencing investor sentiment positively.

Study Overview: Eli Lilly and Company is conducting a study titled ‘Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in ...

The primary outcome assessed was a diagnosis of erectile dysfunction or the initiation of phosphodiesterase type 5 (PDE-5) inhibitor therapy, which is commonly used to treat ED. The study yielded the ...

Assessment of sexual dysfunction among adult male survivors of childhood cancer has primarily been limited to erectile dysfunction. This study aimed to characterize sexual functioning more ...